TCL Archive Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer November 1, 2012
TCL Archive In Brief: William Paul to Head AIDS Research Officer; Schachman Is NIH Extramural Obudsman February 25, 1994
TCL Archive ACS To open Key Positions To Competition In Massive “Reorganization for the ‘90’s August 6, 1993
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly November 17, 1989
